News | July 27, 2015

BioOutsource Opens New Facility In Glasgow

BioOutsource

Doubles the Company’s Capacity for Biologics Contract Testing and Biosimilar Characterisation in Response to Surging Demand, and Creates 50 New Jobs

BioOutsource Ltd. (“BioOutsource”), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, recently announced the opening of a new facility which doubles Biooutsource’s capacity for future growth.

“Our opening of this new, state-of-the-art facility demonstrates our commitment to our growing list of global customers,” commented BioOutsource CEO, Gerry MacKay. “Demand for our services remains high and we are doubling our capacity to make sure we are ready to support the robust pipeline of biotech and biosimilar products currently in development.

It is estimated that in opening and running the new facility, BioOutsource will create approximately 50 new jobs for scientific and technical professionals in the next six months.

Mr. MacKay continued, “This is a great opportunity for Life Science professionals to join an exciting and rapidly growing company. With the recent acquisition by Sartorius Stedim Biotech we expect to become one of the largest employers in this sector in Scotland and further investment in new services is already planned”.

About BioOutsource Ltd
Now part of Sartorius Stedim Biotech Group, BioOutsource provides contract testing services to the biopharmaceutical industry. Our core offering includes a comprehensive range of services to support the testing of biologics, vaccines & biosimilars throughout their development. We possess an unparalleled combination of commercial, regulatory and technical knowledge that enables us to truly stand out as the industry’s increasingly preferred testing partner. We understand the importance of our service to support our client’s critical testing requirements and as a result, continually strive to provide a world class service globally. For more information, visit www.biooutsource.com.

Source: BioOutsource Ltd.